References
- Emile J-F, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127(22):2672–81. doi:10.1182/blood-2016-01-690636.
- Bonometti A. The triptych of mixed histiocytosis: a systematic review of 105 cases and proposed clinical classification. Leuk Lymphoma. 2021;62(1):32–44. doi:10.1080/10428194.2020.1824070.
- Wang KH, Cheng CJ, Hu CH, Lee WR. Coexistence of localized Langerhans cell histiocytosis and cutaneous Rosai-Dorfman disease. Br J Dermatol. 2002;147(4):770–4. doi:10.1046/j.1365-2133.2002.04879.x.
- O'Malley DP, Duong A, Barry TS, Chen S, Hibbard MK, Ferry JA, Hasserjian RP, Thompson MA, Richardson MS, Jaffe R, et al. Co-occurrence of Langerhans cell histiocytosis and Rosai-Dorfman disease: possible relationship of two histiocytic disorders in rare cases. Mod Pathol. 2010;23(12):1616–23. doi:10.1038/modpathol.2010.157.
- Ishikawa M, Endo Y, Uehara A, Suto M, Yasuda M, Motegi S-I, Ishikawa O. Cutaneous adult xanthogranuloma with a small portion of BRAFV600E mutated Langerhans cell histiocytosis populations: a case report and the review of published work. J Dermatol. 2019;46(2):161–5. doi:10.1111/1346-8138.14725.
- Bonometti A, Berti E. Reticulohistiocytoses: a revision of the full spectrum. J Eur Acad Dermatol Venereol. 2020;34(8):1684–94. doi:10.1111/jdv.16214.
- Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile J-F, Durham BH, Braier J, Charlotte F, Donadieu J, et al. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood. 2018;131(26):2877–90. doi:10.1182/blood-2018-03-839753.
- Oh B, Lee S, Ke Y, Kimpo M, Yeoh A, Quah TC. A "Wait-and-See" approach to quiescent single-system Langerhans cell histiocytosis to spare children from chemotherapy. Front Pediatr. 2020;8:466. doi:10.3389/fped.2020.00466.